Businesswire12.15.17
The Board of Directors of Apollo Endosurgery Inc. had added David C. Pacitti as an independent director. He began his tenure on Dec. 8.
Pacitti’s appointment expands the Board of Directors to nine, with the exception of the company's CEO, all of whom are independent within the meaning of the applicable NASDAQ listing standards. Pacitti will be a member of the board's Compensation Committee.
“David is a highly accomplished leader in the medical device field, with deep and relevant commercial leadership gained from experience with respected and leading companies in their fields,” Board Chairman Rich Meelia said. “We are very confident that David will add great value to our board and that Apollo will benefit from his insight, judgment and counsel.”
Pacitti is currently the president and CEO of Siemens Medical Solutions, North America, and Head of North America-Siemens Healthineers, where he has responsibility for Siemen’s multi-billion dollar commercial operation in the United States. Prior to his role at Siemens, Pacitti was with Abbott Vascular in a variety of commercial leadership roles. Pacitti is a graduate of Villanova University and serves on the board of directors of the Advanced Medical Technology Association (AdvaMed).
Apollo Endosurgery Inc. designs, develops, and commercializes treatments for obesity, a condition facing over 600 million people globally, as well as other gastrointestinal disorders. Apollo’s device-based therapies are an alternative to invasive surgical procedures. Apollo's products are offered in over 80 countries.
Pacitti’s appointment expands the Board of Directors to nine, with the exception of the company's CEO, all of whom are independent within the meaning of the applicable NASDAQ listing standards. Pacitti will be a member of the board's Compensation Committee.
“David is a highly accomplished leader in the medical device field, with deep and relevant commercial leadership gained from experience with respected and leading companies in their fields,” Board Chairman Rich Meelia said. “We are very confident that David will add great value to our board and that Apollo will benefit from his insight, judgment and counsel.”
Pacitti is currently the president and CEO of Siemens Medical Solutions, North America, and Head of North America-Siemens Healthineers, where he has responsibility for Siemen’s multi-billion dollar commercial operation in the United States. Prior to his role at Siemens, Pacitti was with Abbott Vascular in a variety of commercial leadership roles. Pacitti is a graduate of Villanova University and serves on the board of directors of the Advanced Medical Technology Association (AdvaMed).
Apollo Endosurgery Inc. designs, develops, and commercializes treatments for obesity, a condition facing over 600 million people globally, as well as other gastrointestinal disorders. Apollo’s device-based therapies are an alternative to invasive surgical procedures. Apollo's products are offered in over 80 countries.